Second crossclamp to perfect degenerative mitral valve repair: Decision-making algorithm, safety, and outcomes
- PMID: 31810650
- DOI: 10.1016/j.jtcvs.2019.09.149
Second crossclamp to perfect degenerative mitral valve repair: Decision-making algorithm, safety, and outcomes
Abstract
Objectives: Residual mitral regurgitation reduces the efficacy of mitral repair and is associated with worse outcomes. We adopted a policy using a second bypass run for patients with residual mitral regurgitation (>+1) and described our decision-making algorithm and outcomes.
Methods: From January 1, 2011, to December 31, 2016, 40 patients with degenerative disease underwent a second bypass run to address residual mitral regurgitation. The echocardiographic criteria for a second bypass run was the presence of moderate or greater mitral regurgitation or mild mitral regurgitation with unfavorable mechanism.
Results: A second bypass run was used in 40 patients. The mean age was 57.3 ± 13.5 years (21-79 years), and 14 patients (35%) were asymptomatic. Residual mitral regurgitation was mild in 25 patients, moderate in 9 patients, and moderate/severe in 6 patients. The cause of postbypass mitral regurgitation was technical or residual pathology in 35 patients and systolic anterior motion in 5 patients. Re-repair techniques were cleft closure in 22 patients, primary suture repair in 13 patients, and expanded polytetrafluoroethylene chordoplasty in 9 patients. After re-repair, 34 patients (85%) had no mitral regurgitation, 4 patients (10%) had trace mitral regurgitation, and 2 patients (5%) had mild mitral regurgitation. Median total cardiopulmonary bypass time was 208.5 minutes, first crossclamp time was 106 minutes, and second crossclamp time was 34 ± 12 minutes. Median intensive care stay was 2 days, and hospital stay was 8 days. On discharge, there was no mitral regurgitation in 13 patients (33%), trace in 23 patients (58%), and mild mitral regurgitation in 4 patients (10%). Freedom from moderate or greater mitral regurgitation at 5 years was 100%.
Conclusions: Residual mitral regurgitation can be effectively treated using a second bypass run with good long-term outcome and minimal incremental risk.
Keywords: degenerative mitral disease; mitral regurgitation; mitral repair; residual mitral regurgitation.
Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Comment in
-
Commentary: Mitral valve re-repair: Rejection of imperfection.J Thorac Cardiovasc Surg. 2020 Nov;160(5):1192-1193. doi: 10.1016/j.jtcvs.2019.10.064. Epub 2019 Oct 25. J Thorac Cardiovasc Surg. 2020. PMID: 31926690 No abstract available.
-
Commentary: Residual mitral regurgitation: The fork in the road.J Thorac Cardiovasc Surg. 2020 Nov;160(5):1193-1194. doi: 10.1016/j.jtcvs.2019.10.169. Epub 2019 Nov 20. J Thorac Cardiovasc Surg. 2020. PMID: 31928812 No abstract available.
-
Commentary: In the pursuit of perfect mitral valve repair: A stitch in time saves nine.J Thorac Cardiovasc Surg. 2020 Nov;160(5):1191-1192. doi: 10.1016/j.jtcvs.2019.11.033. Epub 2019 Nov 27. J Thorac Cardiovasc Surg. 2020. PMID: 31987608 No abstract available.
-
Commentary: Bridging the arch in Loey-Dietz syndrome.J Thorac Cardiovasc Surg. 2020 Nov;160(5):1176-1177. doi: 10.1016/j.jtcvs.2020.07.057. Epub 2020 Jul 19. J Thorac Cardiovasc Surg. 2020. PMID: 32800366 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
